141 related articles for article (PubMed ID: 37071121)
21. Extracorporeal photopheresis as second-line treatment therapy in life-threatening primary graft dysfunction following lung transplantation.
Robinson CA; Inci I; Naegeli M; Murer C; Schuurmans MM; Urosevic-Maiwald M; Schüpbach R; Weder W; Benden C
Pediatr Transplant; 2018 May; 22(3):e13145. PubMed ID: 29380491
[TBL] [Abstract][Full Text] [Related]
22. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
Jaksch P; Scheed A; Keplinger M; Ernst MB; Dani T; Just U; Nahavandi H; Klepetko W; Knobler R
J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
[TBL] [Abstract][Full Text] [Related]
23. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
Lucid CE; Savani BN; Engelhardt BG; Shah P; Clifton C; Greenhut SL; Vaughan LA; Kassim A; Schuening F; Jagasia M
Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
Benden C; Speich R; Hofbauer GF; Irani S; Eich-Wanger C; Russi EW; Weder W; Boehler A
Transplantation; 2008 Dec; 86(11):1625-7. PubMed ID: 19077900
[TBL] [Abstract][Full Text] [Related]
25. Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience.
Leroux J; Hirschi S; Essaydi A; Bohbot A; Degot T; Schuller A; Olland A; Kessler R; Renaud-Picard B
Respir Med Res; 2022 May; 81():100913. PubMed ID: 35525096
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Pecoraro Y; Carillo C; Diso D; Mantovani S; Cimino G; De Giacomo T; Troiani P; Shafii M; Gherzi L; Amore D; Rendina EA; Venuta F; Anile M
Transplant Proc; 2017 May; 49(4):695-698. PubMed ID: 28457374
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
Boluda B; Solana-Altabella A; Cano I; Acuña-Cruz E; Rodríguez-Veiga R; Ballesta-López O; Megías-Vericat JE; Martínez-Cuadrón D; Gómez I; Solves P; Lorenzo I; Piñana JL; Sanz J; Guerreiro M; Montoro Gómez J; Díaz-González A; Marco J; Blanco A; Sanz MÁ; Montesinos P
J Clin Apher; 2021 Aug; 36(4):612-620. PubMed ID: 33964038
[TBL] [Abstract][Full Text] [Related]
28. Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis.
Bozzini S; Bozza E; Bagnera C; Del Fante C; Barone E; De Vitis S; De Amici M; Testa G; Croce S; Valsecchi C; Avanzini MA; Cacciatore R; Mortellaro C; Viarengo G; Perotti C; Meloni F
J Transl Med; 2024 Mar; 22(1):276. PubMed ID: 38486224
[TBL] [Abstract][Full Text] [Related]
29. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study.
Dal MS; Batgi H; Erkurt MA; Hindilerden IY; Kuku I; Kurtoglu E; Kaya E; Besisik SK; Berber I; Nalcaci M; Ulas T; Altuntas F
Transfus Apher Sci; 2021 Oct; 60(5):103243. PubMed ID: 34420879
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal photopheresis for the treatment of chronic graft versus host disease.
Kansu E; Ward D; Sanchez AP; Cunard R; Hayran M; Huseyin B; Vaughan M; Ku G; Curtin P; Mulroney C; Costello C; Castro JE; Wieduwilt M; Corringham S; Ihasz-Davis A; Nelson C; Ball ED
Hematology; 2022 Dec; 27(1):785-794. PubMed ID: 35802815
[TBL] [Abstract][Full Text] [Related]
34. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.
Greinix HT; van Besien K; Elmaagacli AH; Hillen U; Grigg A; Knobler R; Parenti D; Reddy V; Theunissen K; Michallet M; Flowers ME;
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1775-82. PubMed ID: 21621629
[TBL] [Abstract][Full Text] [Related]
35. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
McInnis MC; Ma J; Karur GR; Houbois C; Levy L; Havlin J; Fuchs E; Tikkanen J; Chow CW; Huszti E; Martinu T
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34949699
[TBL] [Abstract][Full Text] [Related]
36. Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience.
Teszak T; Assabiny A; Kiraly A; Tarjanyi Z; Parazs N; Szakal-Toth Z; Hartyanszky I; Szabolcs Z; Racz K; Reti M; Merkely B; Sax B
Transpl Immunol; 2023 Aug; 79():101853. PubMed ID: 37196865
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD).
Mankarious M; Matthews NC; Snowden JA; Alfred A
Front Immunol; 2020; 11():81. PubMed ID: 32082329
[TBL] [Abstract][Full Text] [Related]
38. Management of chronic rejection after lung transplantation.
Bedair B; Hachem RR
J Thorac Dis; 2021 Nov; 13(11):6645-6653. PubMed ID: 34992842
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
[TBL] [Abstract][Full Text] [Related]
40. Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden.
Schain F; Boissin C; Laczik T; Fedeli S; Remberger M; Blennow O; Dykes J; Eich T; Jones C; Mattsson J; Berlin G
Transfus Apher Sci; 2023 Jun; 62(3):103705. PubMed ID: 36967367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
